Surviving change: The metabolic journey of hematopoietic stem cells

Trends in Cell Biology

Volumn 24, Issue 8, 2014, Pages 479-487

  Kohli, Latika ^a   Passegué, Emmanuelle ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood; Fatty acid oxidation; Glycolysis; Hematopoietic stem cells; Quiescence; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER KINASE B1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

BIOENERGY; CANCER STEM CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL METABOLISM; CELL QUIESCENCE; CELL RENEWAL; CELL SURVIVAL; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CITRIC ACID CYCLE; CYTOLOGY; DNA DAMAGE; FATTY ACID OXIDATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; MITOCHONDRION; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; ENERGY METABOLISM; METABOLISM;

ANIMALS; CELL LINEAGE; CELLULAR REPROGRAMMING; ENERGY METABOLISM; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MITOCHONDRIA;

EID: 84904739356     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2014.04.001     Document Type: Review

References (83)

1. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
2. Pietras E.M., et al. Cell cycle regulation in hematopoietic stem cells. J. Cell Biol. 2011, 195:709-720.
3. Passegué E., et al. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 2005, 202:1599-1611.
4. Wilson A., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129.
5. Foudi A., et al. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat. Biotechnol. 2009, 27:84-90.
6. Geiger H., et al. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 2013, 13:376-389.
7. Rossi D.J., et al. Stems cells and the pathways to aging and cancer. Cell 2008, 132:681-696.
8. Shyh-Chang N., et al. Stem cell metabolism in tissue development and aging. Development 2013, 140:2535-2547.
9. Vander Heiden M.G., et al. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
10. Orford K.W., Scadden D.T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 2008, 9:115-128.
11. Bakker S.T., Passegué E. Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells. Exp. Hematol. 2013, 41:915-923.
12. Simsek T., et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010, 7:380-390.
13. Norddahl G.L., et al. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 2011, 8:499-510.
14. Takubo K., et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 2013, 12:49-61.
15. Folmes C.D., et al. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 2012, 11:596-606.
16. Parmar K., et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5431-5436.
17. Eliasson P., Jönsson J.I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J. Cell. Physiol. 2010, 222:17-22.
18. Suda T., et al. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011, 9:298-310.
19. 2 distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys. J. 2001, 81:685-696.
20. Takubo K., et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010, 7:391-402.
21. Nombela-Arrieta C., et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat. Cell Biol. 2013, 15:533-543.
22. Sandau K.B., et al. Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 2001, 276:39805-39811.
23. Haeberle H.A., et al. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS ONE 2008, 3:e3352.
24. Miharada K., et al. Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell 2011, 9:330-344.
25. Kocabas F., et al. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 2012, 120:4963-4972.
26. Wu M., et al. Imaging hematopoietic precursor division in real time. Cell Stem Cell 2007, 1:541-554.
27. Carracedo A., et al. Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 2013, 13:227-232.
28. Takahashi S., et al. New therapeutic target for metabolic syndrome: PPARdelta. Endocr. J. 2007, 54:347-357.
29. Ito K., et al. A PML-PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat. Med. 2012, 18:1350-1358.
30. Ito K., et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008, 453:1072-1078.
31. Carracedo A., et al. A metabolic prosurvival role for PML in breast cancer. J. Clin. Invest. 2012, 122:3088-3100.
32. Vernier M., et al. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev. 2011, 25:41-50.
33. Sharpless N.E., DePinho R.A. How stem cells age and why this makes us grow old. Nat. Rev. Mol. Cell Biol. 2007, 8:703-713.
34. Attema J.L., et al. Hematopoietic stem cell ageing is uncoupled from p16 INK4A-mediated senescence. Oncogene 2009, 28:2238-2243.
35. Bondar T., Medzhitov R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 2010, 6:309-322.
36. Morrison S.J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006, 441:1068-1074.
37. Xu X., et al. Mitochondrial regulation in pluripotent stem cells. Cell Metab. 2013, 18:325-332.
38. Facucho-Oliveira J.M., et al. Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J. Cell Sci. 2007, 120:4025-4034.
39. Suhr S.T., et al. Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 2010, 5:e14095.
40. Yu W.M., et al. Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell 2013, 12:62-74.
41. Jang Y.Y., Sharkis S.J. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007, 110:3056-3063.
42. Owusu-Ansah E., Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009, 461:537-541.
43. Ito K., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 2006, 12:446-451.
44. Tothova Z., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339.
45. Le Belle J.E., et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 2011, 8:59-71.
46. Asai T., et al. The p53 tumor suppressor protein regulates hematopoietic stem cell fate. J. Cell. Physiol. 2011, 226:2215-2221.
47. Hoesel B., Schmid J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 2013, 12:86.
48. Doyle K., Fitzpatrick F.A. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2 and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem. 2010, 285:17417-17424.
49. Joshi A., Kundu M. Mitophagy in hematopoietic stem cells: the case for exploration. Autophagy 2013, 9:1737-1749.
50. Mortensen M., et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 2011, 208:455-467.
51. Warr M.R., et al. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013, 494:323-327.
52. Taniguchi Ishikawa E., et al. Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:9071-9076.
53. Maryanovich M., et al. The ATM-BID pathway regulates quiescence and survival of hematopoietic stem cells. Nat. Cell Biol. 2012, 14:535-541.
54. Maryanovich M., Gross A. A ROS rheostat for cell fate regulation. Trends Cell Biol. 2013, 23:129-134.
55. Opferman J.T., et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
56. Chen Y.B., et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner mitochondrial potential. J. Cell Biol. 2011, 195:263-276.
57. 0 ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
58. Perciavalle R.M., et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat. Cell Biol. 2012, 14:575-583.
59. Laplante M., Sabatini D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122:3589-3594.
60. Song M.S., et al. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 2012, 13:283-296.
61. Yilmaz O.H., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
62. Zhang J., et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006, 441:518-522.
63. Chen C., et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 2008, 205:2397-2408.
64. Gan B., et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19384-19389.
65. Kharas M.G., et al. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 2010, 115:1406-1415.
66. Juntilla M.M., et al. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 2010, 115:4030-4038.
67. Magee J.A., et al. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. Cell Stem Cell 2012, 11:415-428.
68. Brown N.F., et al. The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes. Metabolism 2007, 56:1500-1507.
69. Sengupta S., et al. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010, 468:1100-1104.
70. Luo Z., et al. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 2010, 6:457-470.
71. Gan B., et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 2010, 468:701-704.
72. Gurumurthy S., et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 2010, 468:659-663.
73. Nakada D., et al. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 2010, 468:653-658.
74. Egan D., et al. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 2011, 7:643-644.
75. Kim J., et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13:132-141.
76. Passegue E., et al. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(Suppl. 1):11842-11849.
77. Jordan C.T., et al. Cancer stem cells. N. Engl. J. Med. 2006, 355:1253-1261.
78. Lagadinou E.D., et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 2013, 12:329-341.
79. Samudio I., et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 2010, 120:142-156.
80. Mohrin M., et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010, 7:174-185.
81. Callens C., et al. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J. Exp. Med. 2010, 207:731-750.
82. Kalaitzidis D., et al. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell Stem Cell 2012, 11:429-439.
83. Guo W., et al. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008, 453:529-533.